The clinical value of therapeutic plasma exchange in multifocal motor neuropathy

Helmar C Lehmann1, Felix R Hoffmann, Andreas Fusshoeller

  • 1Department of Neurology, Heinrich-Heine-University of Düsseldorf, Germany. helmar.lehmann@uni-duesseldorf.de

Abstract

Insights

Plasma exchange (PE) offers limited benefit for multifocal motor neuropathy (MMN), despite transiently reducing anti-ganglioside antibodies. Continued axonal degeneration suggests PE alone is insufficient for substantial disease modification in MMN patients.

Area of Science:

  • Neurology
  • Immunology
  • Neuron science

Background:

  • Humoral factors are implicated in multifocal motor neuropathy (MMN) pathogenesis.
  • Plasma exchange (PE) is generally considered ineffective for MMN treatment.

Purpose of the Study:

  • To investigate reasons for the perceived ineffectiveness of PE in MMN.
  • To evaluate the impact of PE on clinical response, electrophysiology, and antibody titers in MMN patients.

Main Methods:

  • Retrospective analysis of seven MMN patients undergoing 4-18 PE sessions.
  • Review of clinical outcomes, electrophysiological parameters, and anti-ganglioside antibody titers.

Main Results:

  • Two patients with anti-ganglioside antibodies showed transient clinical improvement.
  • Electrophysiological parameters worsened in all patients despite PE.
  • Anti-ganglioside antibody titers decreased during PE but rebounded afterward.

Conclusions:

  • PE has limited therapeutic value in MMN, potentially serving as an adjunctive therapy for a subset of patients.
  • Transient reduction of pathogenic humoral factors suggests PE's temporary effect.
  • PE alone cannot prevent axonal degeneration, explaining its limited impact on MMN progression.